Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-19 9:46 pm Purchase | 2025-06-20 | 13G | NextCure, Inc. NXTC | Simcere Zaiming, Inc. | 338,636 12.700% | 338,636 (New Position) | Filing History |
| 2025-05-12 12:54 pm Purchase | 2025-03-31 | 13G | NextCure, Inc. NXTC | CITIGROUP INC C | 100,433 4.300% | 100,433 (New Position) | Filing History |
| 2025-02-14 1:40 pm Sale | 2024-12-31 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 0 0.000% | -208,333 (Position Closed) | Filing History |
| 2024-11-14 6:59 pm Purchase | 2024-09-30 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 208,333 8.900% | 41,628 (+24.97%) | Filing History |
| 2024-11-13 4:06 pm Purchase | 2024-09-30 | 13G | NextCure, Inc. NXTC | Affinity Healthcare Fund, LP | 191,883 8.220% | 52,480 (+37.65%) | Filing History |
| 2024-06-27 4:47 pm Purchase | 2024-06-20 | 13G | NextCure, Inc. NXTC | Affinity Healthcare Fund, LP | 139,403 5.980% | 139,403 (New Position) | Filing History |
| 2024-04-01 6:34 pm Purchase | 2024-04-01 | 13G | NextCure, Inc. NXTC | Logos Global Management LP | 166,705 7.200% | 166,705 (New Position) | Filing History |
| 2024-03-08 4:34 pm Sale | 2024-03-06 | 13D | NextCure, Inc. NXTC | ORBIMED ADVISORS LLC | 105,668 4.500% | -120,250 (-53.23%) | Filing History |
| 2024-01-19 4:26 pm Sale | 2023-12-31 | 13G | NextCure, Inc. NXTC | Millennium Management LLC | 95,032 4.100% | -25,791 (-21.35%) | Filing History |
| 2023-02-06 3:02 pm Sale | 2022-12-31 | 13G | NextCure, Inc. NXTC | Lilly Asia Ventures Fund III L.P. | 0 0.000% | -142,033 (Position Closed) | Filing History |
| 2023-01-24 4:23 pm Purchase | 2023-01-19 | 13G | NextCure, Inc. NXTC | Millennium Management LLC | 120,824 5.200% | 120,824 (New Position) | Filing History |
| 2022-02-09 12:20 pm Sale | 2021-12-31 | 13G | NextCure, Inc. NXTC | Lilly Asia Ventures Fund III L.P. | 142,033 6.200% | -32,039 (-18.41%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | NextCure, Inc. NXTC | BlackRock Inc. BLK | 100,391 3.200% | -25,830 (-20.46%) | Filing History |
| 2021-05-10 4:04 pm Sale | 2021-04-30 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 33,327 1.400% | -148,475 (-81.67%) | Filing History |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | NextCure, Inc. NXTC | Great Point Partners, LLC | 0 0.000% | -114,711 (Position Closed) | Filing History |
| 2021-02-12 10:11 am Sale | 2020-12-31 | 13G | NextCure, Inc. NXTC | LORD, ABBETT & CO. LLC | 0 0.000% | -120,192 (Position Closed) | Filing History |
| 2021-02-11 2:11 pm Purchase | 2020-12-31 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 181,802 7.900% | 25,220 (+16.11%) | Filing History |
| 2021-02-03 2:52 pm Sale | 2020-12-31 | 13G | NextCure, Inc. NXTC | CANAAN X L.P. | 69,870 3.000% | -118,000 (-62.81%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | NextCure, Inc. NXTC | BlackRock Inc. BLK | 126,220 5.500% | 126,220 (New Position) | Filing History |
| 2020-10-26 4:02 pm Purchase | 2020-10-15 | 13G | NextCure, Inc. NXTC | MORGAN STANLEY MS | 156,582 6.800% | 156,582 (New Position) | Filing History |